MetaCap

CryoPort Earnings

NASDAQ: CYRXHealth CareBiotechnology: Pharmaceutical PreparationsUSD

17.35+0.45 (+2.66%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Next earnings date

Tue, Nov 3, 2026

Fiscal period

Sep/2026

EPS estimate

$-0.19

CryoPort earnings summary

CryoPort is scheduled to report Sep/2026 earnings on Nov 3, 2026, with analysts expecting EPS of $-0.19. In its most recent report on Aug 6, 2026 (Q2 2026), CYRX posted EPS of $-0.20. Revenue for the quarter was $49.0 million.

Quarterly EPS is down 109.4% from the same quarter a year earlier. Across the last 16 reports, CYRX shares moved an average of 8.6% (in either direction) in the first trading session after results, rising 9 times and falling 7 times.

Summary generated from market data by MetaCap's automated system. Methodology

CYRX earnings history

CryoPort reported EPS versus estimates
Report dateEPS est.EPS actualSurprisePrice reaction
Aug 6, 2026—$-0.20—+0.9%
May 5, 2026—$-0.25—-3.4%
Mar 5, 2026—$-0.27—-3.3%
Nov 6, 2025—$-0.18—+3.5%
Aug 12, 2025—$2.13—+4.2%
May 8, 2025—$-0.28—-5.5%
Mar 7, 2025—$-0.42—+2.9%
Nov 7, 2024—$-0.02—-9.6%
Aug 8, 2024—$-1.62—+9.5%
May 8, 2024—$-0.43—-5.1%
Mar 13, 2024—$-1.32—+15.9%
Nov 9, 2023—$-0.31—+18.3%
Aug 9, 2023—$-0.42—+0.3%
May 4, 2023—$-0.16—-16.1%
Feb 28, 2023—$-0.24—-18.2%
Nov 4, 2022—$-0.15—+20.5%

Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.

Related